Boisjoly H M, Dubé I, Laughrea P A, Roy R, Bernard P M
Unité de Recherche en Ophtalmologie, Centre Hospitalier de l'Université Laval, Ste-Foy, Québec.
Clin Invest Med. 1989 Aug;12(4):221-3.
One hundred and fifty-two consecutive corneal transplants were performed with recipients selected on the basis of the best HLA-A, B, and DR match, and observed for corneal transplant rejection episodes. Following a descriptive analysis of data, the transplants were subdivided into well matched transplants (109 cases) and poorly matched transplants (43 cases). The rejection rate of poorly matched transplants was 2.37 times higher than that of well matched transplants (p = 0.09). Analysis of survival curves, three years after transplantation, shows a 91% rejection-free survival of well matched transplants compared to 78% for poor matched transplants. These findings suggest that the risk of corneal transplant rejection may be reduced by optimal HLA-A, B, and DR matching.
连续进行了152例角膜移植手术,根据最佳的HLA - A、B和DR匹配情况选择受者,并观察角膜移植排斥反应事件。在对数据进行描述性分析后,将移植分为匹配良好的移植(109例)和匹配不良的移植(43例)。匹配不良的移植排斥率比匹配良好的移植高2.37倍(p = 0.09)。移植三年后的生存曲线分析显示,匹配良好的移植无排斥生存率为91%,而匹配不良的移植为78%。这些发现表明,通过优化HLA - A、B和DR匹配,可能降低角膜移植排斥的风险。